Low LDL-C level and intracranial haemorrhage risk after ischaemic stroke: a prospective cohort study

BACKGROUND AND PURPOSE: The Treat Stroke to Target trial has confirmed the benefit of targeting low-density lipoprotein cholesterol (LDL-C) of <1.8 mmol/L in patients who had an ischaemic stroke (IS). However, haemorrhagic risk brought by this target level (<1.8 mmol/L) or even lower level (&l...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jie, Chen, Zimo, Wang, Meng, Mo, Jinglin, Jing, Jing, Yalkun, Gulbahram, Dai, Liye, Meng, Xia, Li, Hao, Li, Zixiao, Wang, Yongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176994/
https://www.ncbi.nlm.nih.gov/pubmed/36162902
http://dx.doi.org/10.1136/svn-2022-001612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176994/
https://www.ncbi.nlm.nih.gov/pubmed/36162902
http://dx.doi.org/10.1136/svn-2022-001612

Ejemplares similares